<?xml version="1.0" encoding="UTF-8" ?>
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</dc:title>
<dc:creator>Gekas, Christos</dc:creator>
<dc:creator>Teresa, D'Altri 1984-</dc:creator>
<dc:creator>Aligué, Rosa</dc:creator>
<dc:creator>González, Jessica</dc:creator>
<dc:creator>Espinosa Blay, Lluís</dc:creator>
<dc:creator>Bigas Salvans, Anna</dc:creator>
<dc:subject>Leucèmia aguda -- Aspectes genètics</dc:subject>
<dc:description>Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</dc:description>
<dc:description>This research was funded by the Worldwide Cancer Research (formerly AICR, 13-0064), Fundación AECC (Cancer infantil), Ministerio de Economía y Competitividad (SAF2013-40922-R), Red Temática de Investigación Cooperativa en Cáncer (RD12/0036/0054), Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR) (2014SGR-124) to AB</dc:description>
<dc:date>2016</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
<dc:identifier>Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</dc:identifier>
<dc:identifier>0887-6924</dc:identifier>
<dc:identifier>http://hdl.handle.net/10230/27424</dc:identifier>
<dc:identifier>http://dx.doi.org/10.1038/leu.2016.106</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Leukemia. 2016 Oct;30(10):2002-10</dc:relation>
<dc:rights>© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>Nature Publishing Group</dc:publisher>
</oai_dc:dc>
<?xml version="1.0" encoding="UTF-8" ?>
<d:DIDL schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:Item id="hdl_10230_27424">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10230/27424</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</dc:title>
<dc:creator>Gekas, Christos</dc:creator>
<dc:creator>Teresa, D'Altri 1984-</dc:creator>
<dc:creator>Aligué, Rosa</dc:creator>
<dc:creator>González, Jessica</dc:creator>
<dc:creator>Espinosa Blay, Lluís</dc:creator>
<dc:creator>Bigas Salvans, Anna</dc:creator>
<dc:description>Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</dc:description>
<dc:date>2016-10-24T09:06:49Z</dc:date>
<dc:date>2016</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</dc:identifier>
<dc:identifier>0887-6924</dc:identifier>
<dc:identifier>http://hdl.handle.net/10230/27424</dc:identifier>
<dc:identifier>http://dx.doi.org/10.1038/leu.2016.106</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Leukemia. 2016 Oct;30(10):2002-10</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</dc:rights>
<dc:publisher>Nature Publishing Group</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10230_27424_1">
</d:Component>
</d:Item>
</d:DIDL>
<?xml version="1.0" encoding="UTF-8" ?>
<dim:dim schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field element="contributor" lang="ca" mdschema="dc" qualifier="author">Gekas, Christos</dim:field>
<dim:field element="contributor" lang="ca" mdschema="dc" qualifier="author">Teresa, D'Altri 1984-</dim:field>
<dim:field element="contributor" lang="ca" mdschema="dc" qualifier="author">Aligué, Rosa</dim:field>
<dim:field element="contributor" lang="ca" mdschema="dc" qualifier="author">González, Jessica</dim:field>
<dim:field element="contributor" lang="ca" mdschema="dc" qualifier="author">Espinosa Blay, Lluís</dim:field>
<dim:field element="contributor" lang="ca" mdschema="dc" qualifier="author">Bigas Salvans, Anna</dim:field>
<dim:field element="date" mdschema="dc" qualifier="accessioned">2016-10-24T09:06:49Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="issued">2016</dim:field>
<dim:field element="identifier" lang="ca" mdschema="dc" qualifier="citation">Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="issn">0887-6924</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="uri">http://hdl.handle.net/10230/27424</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="doi">http://dx.doi.org/10.1038/leu.2016.106</dim:field>
<dim:field element="description" lang="ca" mdschema="dc" qualifier="abstract">Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</dim:field>
<dim:field element="description" lang="en" mdschema="dc" qualifier="provenance">Submitted by Biblioteca Ciutadella (web.biblioteca@upf.edu) on 2016-10-24T09:06:49Z/nNo. of bitstreams: 1/ngekas-leu-beta (1).pdf: 3726991 bytes, checksum: 1c8c7929d99ce71d3348191dfd3a818f (MD5)</dim:field>
<dim:field element="description" lang="en" mdschema="dc" qualifier="provenance">Made available in DSpace on 2016-10-24T09:06:49Z (GMT). No. of bitstreams: 1/ngekas-leu-beta (1).pdf: 3726991 bytes, checksum: 1c8c7929d99ce71d3348191dfd3a818f (MD5)/n Previous issue date: 2016</dim:field>
<dim:field element="description" mdschema="dc" qualifier="sponsorship">This research was funded by the Worldwide Cancer Research (formerly AICR, 13-0064), Fundación AECC (Cancer infantil), Ministerio de Economía y Competitividad (SAF2013-40922-R), Red Temática de Investigación Cooperativa en Cáncer (RD12/0036/0054), Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR) (2014SGR-124) to AB</dim:field>
<dim:field element="format" lang="ca" mdschema="dc" qualifier="mimetype">application/pdf</dim:field>
<dim:field element="language" lang="ca" mdschema="dc" qualifier="iso">eng</dim:field>
<dim:field element="publisher" lang="ca" mdschema="dc">Nature Publishing Group</dim:field>
<dim:field element="relation" mdschema="dc" qualifier="ispartof">Leukemia. 2016 Oct;30(10):2002-10</dim:field>
<dim:field element="rights" lang="ca" mdschema="dc">© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</dim:field>
<dim:field element="rights" lang="ca" mdschema="dc" qualifier="accessRights">info:eu-repo/semantics/openAccess</dim:field>
<dim:field element="subject" lang="ca" mdschema="dc" qualifier="other">Leucèmia aguda -- Aspectes genètics</dim:field>
<dim:field element="title" lang="ca" mdschema="dc">β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</dim:field>
<dim:field element="type" lang="ca" mdschema="dc">info:eu-repo/semantics/article</dim:field>
<dim:field element="type" lang="ca" mdschema="dc" qualifier="version">info:eu-repo/semantics/acceptedVersion</dim:field>
</dim:dim>
<?xml version="1.0" encoding="UTF-8" ?>
<thesis schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</title>
<creator>Gekas, Christos</creator>
<creator>Teresa, D'Altri 1984-</creator>
<creator>Aligué, Rosa</creator>
<creator>González, Jessica</creator>
<creator>Espinosa Blay, Lluís</creator>
<creator>Bigas Salvans, Anna</creator>
<description>Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</description>
<date>2016-10-24</date>
<date>2016</date>
<type>info:eu-repo/semantics/article</type>
<identifier>Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</identifier>
<identifier>0887-6924</identifier>
<identifier>http://hdl.handle.net/10230/27424</identifier>
<identifier>http://dx.doi.org/10.1038/leu.2016.106</identifier>
<language>eng</language>
<relation>Leukemia. 2016 Oct;30(10):2002-10</relation>
<rights>info:eu-repo/semantics/openAccess</rights>
<rights>© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</rights>
<publisher>Nature Publishing Group</publisher>
</thesis>
<?xml version="1.0" encoding="UTF-8" ?>
<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield ind1=" " ind2=" " tag="042">
<subfield code="a">dc</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Gekas, Christos</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Teresa, D'Altri 1984-</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Aligué, Rosa</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">González, Jessica</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Espinosa Blay, Lluís</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Bigas Salvans, Anna</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="260">
<subfield code="c">2016</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="520">
<subfield code="a">Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">0887-6924</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">http://hdl.handle.net/10230/27424</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">http://dx.doi.org/10.1038/leu.2016.106</subfield>
</datafield>
<datafield ind1="0" ind2="0" tag="245">
<subfield code="a">β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</subfield>
</datafield>
</record>
<?xml version="1.0" encoding="UTF-8" ?>
<mets ID=" DSpace_ITEM_10230-27424" OBJID=" hdl:10230/27424" PROFILE="DSpace METS SIP Profile 1.0" TYPE="DSpace ITEM" schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd">
<metsHdr CREATEDATE="2022-11-15T23:04:05Z">
<agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
<name>Repositori digital de la UPF</name>
</agent>
</metsHdr>
<dmdSec ID="DMD_10230_27424">
<mdWrap MDTYPE="MODS">
<xmlData schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Gekas, Christos</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Teresa, D'Altri 1984-</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Aligué, Rosa</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>González, Jessica</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Espinosa Blay, Lluís</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Bigas Salvans, Anna</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2016-10-24T09:06:49Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2016</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</mods:identifier>
<mods:identifier type="issn">0887-6924</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10230/27424</mods:identifier>
<mods:identifier type="doi">http://dx.doi.org/10.1038/leu.2016.106</mods:identifier>
<mods:abstract>Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</mods:abstract>
<mods:language>
<mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</mods:accessCondition>
<mods:titleInfo>
<mods:title>β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods>
</xmlData>
</mdWrap>
</dmdSec>
<amdSec ID="FO_10230_27424_1">
<techMD ID="TECH_O_10230_27424_1">
<mdWrap MDTYPE="PREMIS">
<xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
<premis:premis>
<premis:object>
<premis:objectIdentifier>
<premis:objectIdentifierType>URL</premis:objectIdentifierType>
<premis:objectIdentifierValue>http://repositori.upf.edu/bitstream/10230/27424/1/gekas-leu-beta%20%281%29.pdf</premis:objectIdentifierValue>
</premis:objectIdentifier>
<premis:objectCategory>File</premis:objectCategory>
<premis:objectCharacteristics>
<premis:fixity>
<premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
<premis:messageDigest>1c8c7929d99ce71d3348191dfd3a818f</premis:messageDigest>
</premis:fixity>
<premis:size>3726991</premis:size>
<premis:format>
<premis:formatDesignation>
<premis:formatName>application/pdf</premis:formatName>
</premis:formatDesignation>
</premis:format>
</premis:objectCharacteristics>
<premis:originalName>gekas-leu-beta (1).pdf</premis:originalName>
</premis:object>
</premis:premis>
</xmlData>
</mdWrap>
</techMD>
</amdSec>
<amdSec ID="FT_10230_27424_2">
<techMD ID="TECH_T_10230_27424_2">
<mdWrap MDTYPE="PREMIS">
<xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
<premis:premis>
<premis:object>
<premis:objectIdentifier>
<premis:objectIdentifierType>URL</premis:objectIdentifierType>
<premis:objectIdentifierValue>http://repositori.upf.edu/bitstream/10230/27424/2/gekas-leu-beta%20%281%29.pdf.txt</premis:objectIdentifierValue>
</premis:objectIdentifier>
<premis:objectCategory>File</premis:objectCategory>
<premis:objectCharacteristics>
<premis:fixity>
<premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
<premis:messageDigest>f60cb86a1a9ca588f5f47f23d146feda</premis:messageDigest>
</premis:fixity>
<premis:size>44770</premis:size>
<premis:format>
<premis:formatDesignation>
<premis:formatName>text/plain</premis:formatName>
</premis:formatDesignation>
</premis:format>
</premis:objectCharacteristics>
<premis:originalName>gekas-leu-beta (1).pdf.txt</premis:originalName>
</premis:object>
</premis:premis>
</xmlData>
</mdWrap>
</techMD>
</amdSec>
<fileSec>
<fileGrp USE="ORIGINAL">
<file ADMID="FO_10230_27424_1" CHECKSUM="1c8c7929d99ce71d3348191dfd3a818f" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10230_27424_1" ID="BITSTREAM_ORIGINAL_10230_27424_1" MIMETYPE="application/pdf" SEQ="1" SIZE="3726991">
</file>
</fileGrp>
<fileGrp USE="TEXT">
<file ADMID="FT_10230_27424_2" CHECKSUM="f60cb86a1a9ca588f5f47f23d146feda" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10230_27424_2" ID="BITSTREAM_TEXT_10230_27424_2" MIMETYPE="text/plain" SEQ="2" SIZE="44770">
</file>
</fileGrp>
</fileSec>
<structMap LABEL="DSpace Object" TYPE="LOGICAL">
<div ADMID="DMD_10230_27424" TYPE="DSpace Object Contents">
<div TYPE="DSpace BITSTREAM">
</div>
</div>
</structMap>
</mets>
<?xml version="1.0" encoding="UTF-8" ?>
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Gekas, Christos</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Teresa, D'Altri 1984-</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Aligué, Rosa</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>González, Jessica</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Espinosa Blay, Lluís</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Bigas Salvans, Anna</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2016-10-24T09:06:49Z</mods:dateAvailable>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2016</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</mods:identifier>
<mods:identifier type="issn">0887-6924</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10230/27424</mods:identifier>
<mods:identifier type="doi">http://dx.doi.org/10.1038/leu.2016.106</mods:identifier>
<mods:abstract>Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</mods:accessCondition>
<mods:titleInfo>
<mods:title>β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods>
<?xml version="1.0" encoding="UTF-8" ?>
<atom:entry schemaLocation="http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml">
<atom:id>http://oai-repositori.upf.edu/oai/metadata/handle/10230/27424/ore.xml</atom:id>
<atom:updated>2016-10-24T09:06:49Z</atom:updated>
<atom:source>
<atom:generator>Repositori digital de la UPF</atom:generator>
</atom:source>
<atom:title>β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</atom:title>
<atom:author>
<atom:name>Gekas, Christos</atom:name>
</atom:author>
<atom:author>
<atom:name>Teresa, D'Altri 1984-</atom:name>
</atom:author>
<atom:author>
<atom:name>Aligué, Rosa</atom:name>
</atom:author>
<atom:author>
<atom:name>González, Jessica</atom:name>
</atom:author>
<atom:author>
<atom:name>Espinosa Blay, Lluís</atom:name>
</atom:author>
<atom:author>
<atom:name>Bigas Salvans, Anna</atom:name>
</atom:author>
<oreatom:triples>
<rdf:Description about="http://oai-repositori.upf.edu/oai/metadata/handle/10230/27424/ore.xml#atom">
<dcterms:modified>2016-10-24T09:06:49Z</dcterms:modified>
</rdf:Description>
<rdf:Description about="http://repositori.upf.edu/bitstream/10230/27424/3/gekas-leu-beta%20%281%29.pdf.jpg">
<dcterms:description>THUMBNAIL</dcterms:description>
</rdf:Description>
<rdf:Description about="http://repositori.upf.edu/bitstream/10230/27424/1/gekas-leu-beta%20%281%29.pdf">
<dcterms:description>ORIGINAL</dcterms:description>
</rdf:Description>
<rdf:Description about="http://repositori.upf.edu/bitstream/10230/27424/2/gekas-leu-beta%20%281%29.pdf.txt">
<dcterms:description>TEXT</dcterms:description>
</rdf:Description>
</oreatom:triples>
</atom:entry>
<?xml version="1.0" encoding="UTF-8" ?>
<qdc:qualifieddc schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
<dc:title>β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</dc:title>
<dc:creator>Gekas, Christos</dc:creator>
<dc:creator>Teresa, D'Altri 1984-</dc:creator>
<dc:creator>Aligué, Rosa</dc:creator>
<dc:creator>González, Jessica</dc:creator>
<dc:creator>Espinosa Blay, Lluís</dc:creator>
<dc:creator>Bigas Salvans, Anna</dc:creator>
<dcterms:abstract>Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</dcterms:abstract>
<dc:date>2016</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</dc:identifier>
<dc:identifier>0887-6924</dc:identifier>
<dc:identifier>http://hdl.handle.net/10230/27424</dc:identifier>
<dc:identifier>http://dx.doi.org/10.1038/leu.2016.106</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Leukemia. 2016 Oct;30(10):2002-10</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</dc:rights>
<dc:publisher>Nature Publishing Group</dc:publisher>
</qdc:qualifieddc>
<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
<ow:Publication about="oai:repositori.upf.edu:10230/27424">
<dc:title>β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</dc:title>
<dc:creator>Gekas, Christos</dc:creator>
<dc:creator>Teresa, D'Altri 1984-</dc:creator>
<dc:creator>Aligué, Rosa</dc:creator>
<dc:creator>González, Jessica</dc:creator>
<dc:creator>Espinosa Blay, Lluís</dc:creator>
<dc:creator>Bigas Salvans, Anna</dc:creator>
<dc:description>Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</dc:description>
<dc:date>2016</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</dc:identifier>
<dc:identifier>0887-6924</dc:identifier>
<dc:identifier>http://hdl.handle.net/10230/27424</dc:identifier>
<dc:identifier>http://dx.doi.org/10.1038/leu.2016.106</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Leukemia. 2016 Oct;30(10):2002-10</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</dc:rights>
<dc:publisher>Nature Publishing Group</dc:publisher>
</ow:Publication>
</rdf:RDF>
<?xml version="1.0" encoding="UTF-8" ?>
<metadata schemaLocation="http://www.lyncode.com/xoai http://www.lyncode.com/xsd/xoai.xsd">
<element name="dc">
<element name="contributor">
<element name="author">
<element name="ca">
<field name="value">Gekas, Christos</field>
<field name="value">Teresa, D'Altri 1984-</field>
<field name="value">Aligué, Rosa</field>
<field name="value">González, Jessica</field>
<field name="value">Espinosa Blay, Lluís</field>
<field name="value">Bigas Salvans, Anna</field>
</element>
</element>
</element>
<element name="date">
<element name="accessioned">
<element name="none">
<field name="value">2016-10-24T09:06:49Z</field>
</element>
</element>
<element name="issued">
<element name="none">
<field name="value">2016</field>
</element>
</element>
</element>
<element name="identifier">
<element name="citation">
<element name="ca">
<field name="value">Gekas C, D'Altri T, Aligué R, González J, Espinosa L, Bigas A. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016 Oct;30(10):2002-2010. doi: 10.1038/leu.2016.106</field>
</element>
</element>
<element name="issn">
<element name="none">
<field name="value">0887-6924</field>
</element>
</element>
<element name="uri">
<element name="none">
<field name="value">http://hdl.handle.net/10230/27424</field>
</element>
</element>
<element name="doi">
<element name="none">
<field name="value">http://dx.doi.org/10.1038/leu.2016.106</field>
</element>
</element>
</element>
<element name="description">
<element name="abstract">
<element name="ca">
<field name="value">Notch activation is instrumental in the development of most T-cell acute lymphoblastic leukemia (T-ALL) cases, yet Notch mutations alone are not sufficient to recapitulate the full human disease in animal models. We here found that Notch1 activation at the fetal liver (FL) stage expanded the hematopoietic progenitor population and conferred it transplantable leukemic-initiating capacity. However, leukemogenesis and leukemic-initiating cell capacity induced by Notch1 was critically dependent on the levels of β-Catenin in both FL and adult bone marrow contexts. In addition, inhibition of β-Catenin compromised survival and proliferation of human T-ALL cell lines carrying activated Notch1. By transcriptome analyses, we identified the MYC pathway as a crucial element downstream of β-Catenin in these T-ALL cells and demonstrate that the MYC 3' enhancer required β-Catenin and Notch1 recruitment to induce transcription. Finally, PKF115-584 treatment prevented and partially reverted leukemogenesis induced by active Notch1.</field>
</element>
</element>
<element name="provenance">
<element name="en">
<field name="value">Submitted by Biblioteca Ciutadella (web.biblioteca@upf.edu) on 2016-10-24T09:06:49Z/nNo. of bitstreams: 1/ngekas-leu-beta (1).pdf: 3726991 bytes, checksum: 1c8c7929d99ce71d3348191dfd3a818f (MD5)</field>
<field name="value">Made available in DSpace on 2016-10-24T09:06:49Z (GMT). No. of bitstreams: 1/ngekas-leu-beta (1).pdf: 3726991 bytes, checksum: 1c8c7929d99ce71d3348191dfd3a818f (MD5)/n Previous issue date: 2016</field>
</element>
</element>
<element name="sponsorship">
<element name="none">
<field name="value">This research was funded by the Worldwide Cancer Research (formerly AICR, 13-0064), Fundación AECC (Cancer infantil), Ministerio de Economía y Competitividad (SAF2013-40922-R), Red Temática de Investigación Cooperativa en Cáncer (RD12/0036/0054), Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR) (2014SGR-124) to AB</field>
</element>
</element>
</element>
<element name="format">
<element name="mimetype">
<element name="ca">
<field name="value">application/pdf</field>
</element>
</element>
</element>
<element name="language">
<element name="iso">
<element name="ca">
<field name="value">eng</field>
</element>
</element>
</element>
<element name="publisher">
<element name="ca">
<field name="value">Nature Publishing Group</field>
</element>
</element>
<element name="relation">
<element name="ispartof">
<element name="none">
<field name="value">Leukemia. 2016 Oct;30(10):2002-10</field>
</element>
</element>
</element>
<element name="rights">
<element name="ca">
<field name="value">© Nature Publishing Group. http://dx.doi.org/10.1038/leu.2016.106</field>
</element>
<element name="accessRights">
<element name="ca">
<field name="value">info:eu-repo/semantics/openAccess</field>
</element>
</element>
</element>
<element name="subject">
<element name="other">
<element name="ca">
<field name="value">Leucèmia aguda -- Aspectes genètics</field>
</element>
</element>
</element>
<element name="title">
<element name="ca">
<field name="value">β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.</field>
</element>
</element>
<element name="type">
<element name="ca">
<field name="value">info:eu-repo/semantics/article</field>
</element>
<element name="version">
<element name="ca">
<field name="value">info:eu-repo/semantics/acceptedVersion</field>
</element>
</element>
</element>
</element>
<element name="bundles">
<element name="bundle">
<field name="name">THUMBNAIL</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">gekas-leu-beta (1).pdf.jpg</field>
<field name="originalName">gekas-leu-beta (1).pdf.jpg</field>
<field name="description">IM Thumbnail</field>
<field name="format">image/jpeg</field>
<field name="size">13416</field>
<field name="url">http://repositori.upf.edu/bitstream/10230/27424/3/gekas-leu-beta%20%281%29.pdf.jpg</field>
<field name="checksum">0424d58afa9c39c7c48e6c3f8aa793b2</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">3</field>
</element>
</element>
</element>
<element name="bundle">
<field name="name">ORIGINAL</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">gekas-leu-beta (1).pdf</field>
<field name="originalName">gekas-leu-beta (1).pdf</field>
<field name="format">application/pdf</field>
<field name="size">3726991</field>
<field name="url">http://repositori.upf.edu/bitstream/10230/27424/1/gekas-leu-beta%20%281%29.pdf</field>
<field name="checksum">1c8c7929d99ce71d3348191dfd3a818f</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">1</field>
</element>
</element>
</element>
<element name="bundle">
<field name="name">TEXT</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">gekas-leu-beta (1).pdf.txt</field>
<field name="originalName">gekas-leu-beta (1).pdf.txt</field>
<field name="description">Extracted text</field>
<field name="format">text/plain</field>
<field name="size">44770</field>
<field name="url">http://repositori.upf.edu/bitstream/10230/27424/2/gekas-leu-beta%20%281%29.pdf.txt</field>
<field name="checksum">f60cb86a1a9ca588f5f47f23d146feda</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">2</field>
</element>
</element>
</element>
</element>
<element name="others">
<field name="handle">10230/27424</field>
<field name="identifier">oai:repositori.upf.edu:10230/27424</field>
<field name="lastModifyDate">2021-07-26 09:36:40.299</field>
</element>
<element name="repository">
<field name="name">Repositori digital de la UPF</field>
<field name="mail">repositori@upf.edu</field>
</element>
</metadata>